ArticleTechnology in cancer research & treatment

The MiR-200c/FOXP3 Network: A Promising Biomarker for Predicting Trastuzumab Response in HER2-Positive Breast Cancer.

Mohamed S Othman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.